98 related articles for article (PubMed ID: 16298332)
1. In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice.
Naganawa T; Xiao L; Abogunde E; Sobue T; Kalajzic I; Sabbieti M; Agas D; Hurley MM
Biochem Biophys Res Commun; 2006 Jan; 339(2):490-8. PubMed ID: 16298332
[TBL] [Abstract][Full Text] [Related]
2. Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development.
Choi KY; Kim HJ; Lee MH; Kwon TG; Nah HD; Furuichi T; Komori T; Nam SH; Kim YJ; Kim HJ; Ryoo HM
Dev Dyn; 2005 May; 233(1):115-21. PubMed ID: 15765505
[TBL] [Abstract][Full Text] [Related]
3. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.
Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM
J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162
[TBL] [Abstract][Full Text] [Related]
4. Enlarged infarct volume and loss of BDNF mRNA induction following brain ischemia in mice lacking FGF-2.
Kiprianova I; Schindowski K; von Bohlen und Halbach O; Krause S; Dono R; Schwaninger M; Unsicker K
Exp Neurol; 2004 Oct; 189(2):252-60. PubMed ID: 15380477
[TBL] [Abstract][Full Text] [Related]
5. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.
Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V
J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice.
Naganawa T; Xiao L; Coffin JD; Doetschman T; Sabbieti MG; Agas D; Hurley MM
J Cell Biochem; 2008 Apr; 103(6):1975-88. PubMed ID: 17955502
[TBL] [Abstract][Full Text] [Related]
7. Could the effect of modeled microgravity on osteogenic differentiation of human mesenchymal stem cells be reversed by regulation of signaling pathways?
Zheng Q; Huang G; Yang J; Xu Y; Guo C; Xi Y; Pan Z; Wang J
Biol Chem; 2007 Jul; 388(7):755-63. PubMed ID: 17570829
[TBL] [Abstract][Full Text] [Related]
8. Runx2 phosphorylation induced by fibroblast growth factor-2/protein kinase C pathways.
Kim BG; Kim HJ; Park HJ; Kim YJ; Yoon WJ; Lee SJ; Ryoo HM; Cho JY
Proteomics; 2006 Feb; 6(4):1166-74. PubMed ID: 16421932
[TBL] [Abstract][Full Text] [Related]
9. Postnatal growth and bone mass in mice with IGF-I haploinsufficiency.
He J; Rosen CJ; Adams DJ; Kream BE
Bone; 2006 Jun; 38(6):826-35. PubMed ID: 16427371
[TBL] [Abstract][Full Text] [Related]
10. FGF and FGFR signaling in chondrodysplasias and craniosynostosis.
Marie PJ; Coffin JD; Hurley MM
J Cell Biochem; 2005 Dec; 96(5):888-96. PubMed ID: 16149058
[TBL] [Abstract][Full Text] [Related]
11. A local bone anabolic effect of rhFGF2-impregnated gelatin hydrogel by promoting cell proliferation and coordinating osteoblastic differentiation.
Kodama N; Nagata M; Tabata Y; Ozeki M; Ninomiya T; Takagi R
Bone; 2009 Apr; 44(4):699-707. PubMed ID: 19166987
[TBL] [Abstract][Full Text] [Related]
12. Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization.
Fontaine V; Filipe C; Werner N; Gourdy P; Billon A; Garmy-Susini B; Brouchet L; Bayard F; Prats H; Doetschman T; Nickenig G; Arnal JF
Am J Pathol; 2006 Nov; 169(5):1855-62. PubMed ID: 17071606
[TBL] [Abstract][Full Text] [Related]
13. Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose--derived stem cells in vitro and in vivo.
Zhang X; Yang M; Lin L; Chen P; Ma KT; Zhou CY; Ao YF
Calcif Tissue Int; 2006 Sep; 79(3):169-78. PubMed ID: 16969589
[TBL] [Abstract][Full Text] [Related]
14. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination.
Murtie JC; Zhou YX; Le TQ; Vana AC; Armstrong RC
Neurobiol Dis; 2005; 19(1-2):171-82. PubMed ID: 15837572
[TBL] [Abstract][Full Text] [Related]
15. Transient down-regulation of cbfa1/Runx2 by RNA interference in murine C3H10T1/2 mesenchymal stromal cells delays in vitro and in vivo osteogenesis, but does not overtly affect chondrogenesis.
Gordeladze JO; Noël D; Bony C; Apparailly F; Louis-Plence P; Jorgensen C
Exp Cell Res; 2008 Apr; 314(7):1495-506. PubMed ID: 18313048
[TBL] [Abstract][Full Text] [Related]
16. Ovine endometrial expression of fibroblast growth factor (FGF) 2 and conceptus expression of FGF receptors during early pregnancy.
Ocón-Grove OM; Cooke FN; Alvarez IM; Johnson SE; Ott TL; Ealy AD
Domest Anim Endocrinol; 2008 Feb; 34(2):135-45. PubMed ID: 17223006
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.
Montero A; Okada Y; Tomita M; Ito M; Tsurukami H; Nakamura T; Doetschman T; Coffin JD; Hurley MM
J Clin Invest; 2000 Apr; 105(8):1085-93. PubMed ID: 10772653
[TBL] [Abstract][Full Text] [Related]
18. High-dose estrogen-induced osteogenesis is decreased in aged RUNX2(+/-) mice.
Jüttner KV; Perry MJ
Bone; 2007 Jul; 41(1):25-32. PubMed ID: 17475575
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs).
Quarto N; Wan DC; Longaker MT
Bone; 2008 Jun; 42(6):1040-52. PubMed ID: 18420480
[TBL] [Abstract][Full Text] [Related]
20. Microarray analysis on Runx2-deficient mouse embryos reveals novel Runx2 functions and target genes during intramembranous and endochondral bone formation.
Vaes BL; Ducy P; Sijbers AM; Hendriks JM; van Someren EP; de Jong NG; van den Heuvel ER; Olijve W; van Zoelen EJ; Dechering KJ
Bone; 2006 Oct; 39(4):724-38. PubMed ID: 16774856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
